{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:59:19Z","timestamp":1753437559699},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary generalized glucocorticoid hypersensitivity (PGGH) is a very rare disease caused by terminal organ hypersensitivity to glucocorticoids for which the aetiology is unknown. The incidence of PGGH is extremely rare,\u00a0especially in children. To date, the literatures about the etiology, prognosis and treatment of PGGH are scarce. Aim of the study is describing the cases of two Chinese children with infantile-onset PGGH in one family, one of whom died and one who was treated with mifepristone. They are the two youngest children with PGGH reported in the literature.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Two siblings with infantile-onset PGGH were affected in this family. The main manifestations of patient 1 were typical Cushing\u2019s syndrome-like manifestations, significantly aggravated symptoms after physiological doses of glucocorticoids and very low levels of serum cortisol and adrenocorticotropin hormone (ACTH) during attacks. After being diagnosed with PGGH, he was given guidance to avoid glucocorticoids and took mifepristone therapy for 5\u2009months, and his symptoms improved. Patient 2 was the younger brother of patient 1, with similar manifestations to his brother at the age of 4\u2009months. Patient 2 ultimately died at the age of 9\u2009months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PGGH is a very rare disease that can lead to death if not diagnosed and treated in a timely manner. This article describes the cases of the two youngest children with PGGH reported in the literature, one of whom improved after mifepristone treatment, and increases the knowledge of the clinical manifestations of and the treatment experience in PGGH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-022-03722-3","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T10:51:43Z","timestamp":1667904703000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuge","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"3722_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.aace.2021.06.010","volume":"7","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Feng Y, Cao Y, Chen Y, Li F. A Case of Glucocorticoid Hypersensitivity Syndrome Associated With Underlying Rubella Virus Infection. AACE Clin Case Rep. 2021;7:367\u201371.","journal-title":"AACE Clin Case Rep"},{"key":"3722_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000330759","volume":"76","author":"E Charmandari","year":"2011","unstructured":"Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity. Horm Res Paediatr. 2011;76:145\u201355.","journal-title":"Horm Res Paediatr."},{"key":"3722_CR3","first-page":"47","volume":"83","author":"NA Huizenga","year":"1998","unstructured":"Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, et al. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 1998;83:47\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrendo.2013.183","volume":"9","author":"RA Quax","year":"2013","unstructured":"Quax RA, Manenschijn L, Koper JW, Hazes JM, Lamberts SW, van Rossum EF, et al. Glucocorticoid sensitivity in health and disease. Nat Rev Endocrinol. 2013;9:670\u201386.","journal-title":"Nat Rev Endocrinol"},{"key":"3722_CR5","first-page":"124","volume":"16","author":"NC Nicolaides","year":"2017","unstructured":"Nicolaides NC, Charmandari E. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes. Hormones (Athens, Greece). 2017;16:124\u201338.","journal-title":"Hormones (Athens, Greece)"},{"key":"3722_CR6","volume-title":"Endocrine and Metabolic Diseases Symposium and Young and Middle-aged English Forum","author":"C Su","year":"2008","unstructured":"Su C, Yuchuan L, Chunxiu G. A Case of Glucocorticoid Hypersensitivity Syndrome. In: Endocrine and Metabolic Diseases Symposium and Young and Middle-aged English Forum, vol. 2; 2008."},{"key":"3722_CR7","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"RH Oakley","year":"2013","unstructured":"Oakley RH, Cidlowski JA. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132:1033\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"3722_CR8","doi-asserted-by":"publisher","first-page":"27857","DOI":"10.1074\/jbc.274.39.27857","volume":"274","author":"RH Oakley","year":"1999","unstructured":"Oakley RH, Jewell CM, Yudt MR, Bofetiado DM, Cidlowski JA. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem. 1999;274:27857\u201366.","journal-title":"J Biol Chem"},{"key":"3722_CR9","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1128\/MCB.01439-06","volume":"27","author":"LJ Lewis-Tuffin","year":"2007","unstructured":"Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, Collins JB, Cidlowski JA. Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active. Mol Cell Biol. 2007;27:2266\u201382.","journal-title":"Mol Cell Biol"},{"key":"3722_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1128\/MCB.00908-15","volume":"36","author":"B He","year":"2015","unstructured":"He B, Cruz-Topete D, Oakley RH, Xiao X, Cidlowski JA. Human Glucocorticoid Receptor beta Regulates Gluconeogenesis and Inflammation in Mouse Liver. Mol Cell Biol. 2015;36:714\u201330.","journal-title":"Mol Cell Biol"},{"key":"3722_CR11","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1210\/jcem-70-3-729","volume":"70","author":"S Iida","year":"1990","unstructured":"Iida S, Nakamura Y, Fujii H, Nishimura J, Tsugawa M, Gomi M, et al. A patient with hypocortisolism and Cushing's syndrome-like manifestations: cortisol hyperreactive syndrome. J Clin Endocrinol Metab. 1990;70:729.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1210\/jc.2005-2212","volume":"91","author":"H Russcher","year":"2006","unstructured":"Russcher H, Smit P, van Rossum EF, van den Akker EL, Brinkmann AO, de Heide LJ, et al. Strategies for the characterization of disorders in cortisol sensitivity. J Clin Endocrinol Metab. 2006;91:694\u2013701.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR13","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/eci.12554","volume":"45","author":"NC Nicolaides","year":"2015","unstructured":"Nicolaides NC, Lamprokostopoulou A, Polyzos A, Kino T, Katsantoni E, Triantafyllou P, et al. Transient generalized glucocorticoid hypersensitivity. Eur J Clin Investig. 2015;45:1306\u201315.","journal-title":"Eur J Clin Investig"},{"key":"3722_CR14","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1210\/jc.2008-0892","volume":"93","author":"E Charmandari","year":"2008","unstructured":"Charmandari E, Ichijo T, Jubiz W, Baid S, Zachman K, Chrousos GP, et al. A Novel Point Mutation in the Amino Terminal Domain of the Human Glucocorticoid Receptor (hGR) Gene Enhancing hGR-Mediated Gene Expression. J Clin Endocrinol Metab. 2008;93:4963\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000342505","volume":"24","author":"E Charmandari","year":"2013","unstructured":"Charmandari E, Kino T, Chrousos GP. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocr Dev. 2013;24:67\u201385.","journal-title":"Endocr Dev"},{"key":"3722_CR16","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1210\/jc.2018-00352","volume":"103","author":"RJ Santen","year":"2018","unstructured":"Santen RJ, Jewell CM, Yue W, Heitjan DF, Raff H, Katen KS, et al. Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids. J Clin Endocrinol Metab. 2018;103:3630\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR17","first-page":"144","volume":"83","author":"NA Huizenga","year":"1998","unstructured":"Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998;83:144\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR18","first-page":"t5","volume":"5","author":"E Charmandari","year":"2012","unstructured":"Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response. Sci Signal. 2012;5:t5.","journal-title":"Sci Signal"},{"key":"3722_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/cen.12096","volume":"78","author":"KR Koetz","year":"2013","unstructured":"Koetz KR, van Rossum EF, Ventz M, Diederich S, Quinkler M. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy. Clin Endocrinol. 2013;78:831\u20137.","journal-title":"Clin Endocrinol"},{"key":"3722_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40842-020-00105-4","volume":"6","author":"DR Brown","year":"2020","unstructured":"Brown DR, East HE, Eilerman BS, Gordon MB, King EE, Knecht LA, et al. Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations. Clin Diabetes Endocrinol. 2020;6:1\u201318.","journal-title":"Clin Diabetes Endocrinol"},{"key":"3722_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2147\/IJGM.S273969","volume":"13","author":"Y Liu","year":"2020","unstructured":"Liu Y, Han M, Yang J, Xu Q, Xu L, Ren Y, et al. Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report. Int J Gen Med. 2020;13:825\u201331.","journal-title":"Int J Gen Med"},{"key":"3722_CR22","first-page":"14","volume":"85","author":"RS Newfield","year":"2000","unstructured":"Newfield RS, Kalaitzoglou G, Licholai T, Chilton D, Ashraf J, Thompson EB, et al. Normocortisolemic Cushing's syndrome initially presenting with increased glucocorticoid receptor numbers. J Clin Endocrinol Metab. 2000;85:14\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR23","first-page":"124","volume":"28","author":"KA Al-Shoumer","year":"2008","unstructured":"Al-Shoumer KA, Hafez MF, Doi SA. A case of hypocortisolemic clinical Cushing\u2019s syndrome. Ann Saudi Med. 2008;28:124\u20137.","journal-title":"Ann Saudi Med"},{"key":"3722_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40292-016-0153-4","volume":"23","author":"F Ceccato","year":"2016","unstructured":"Ceccato F, Boscaro M. Cushing\u2019s Syndrome: Screening and Diagnosis. High Blood Press Cardiovasc Prev. 2016;23:209\u201315.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"3722_CR25","first-page":"835","volume":"96","author":"Group CPAC","year":"2016","unstructured":"Group CPAC. Consensus of Chinese Experts on diagnosis and treatment of Cushing\u2019s Disease (2015). Natl Med J China. 2016;96:835\u201340.","journal-title":"Natl Med J China"},{"key":"3722_CR26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7727\/wimj.2012.056","volume":"61","author":"R Krysiak","year":"2012","unstructured":"Krysiak R, Okopien B. Glucocorticoid hypersensitivity syndrome--a case report. West Indian Med J. 2012;61:844\u20136.","journal-title":"West Indian Med J"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03722-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03722-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T22:07:21Z","timestamp":1667945241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03722-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03722-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shenzhen Children\u2019s Hospital [No. 2022 (002)]. All of the subjects provided written informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written parental consent for publication was obtained on behalf of each of the children. Written consent for publication was obtained from all of the adults whose information is provided in this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no financial and personal relationships with other people or organizations that could inappropriately influence our work, and there are no professional or other personal interests of any nature or type in any product, service and\/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"650"}}